update on tirzepatide FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Tirzepatide Week 19 Update |

In clinical studies, semaglutide has shown significant effects on HbA1c reduction, weight loss, and cardiovascular risk markers

The key to effectiveness is following the prescribed dosage and combining the medication with healthy lifestyle choices

August 15, 2025: Huge New Ruling U.S

Diet: A balanced diet that focuses on nutrient-dense foods and calorie control is essential

Peptide 20 recognition Superimposition of the TMDs of GIPR, GLP-1R and GCGR bound by peptide 20 shows that the three receptors employed conserved residues in the lower half of the TMD pocket to recognize the well-overlapped peptide N-terminal region (residues 1 to 11), while the peptide C terminus, engaged by ECL1, the N-terminal -helix of ECD and the extracellular tip of TM1, displays receptor-specific positions and orientations (Fig

oral fluconazole should be avoided during pregnancy